IgY ‑ turning the page toward passive immunization in COVID-19 infection (Review)
- Authors:
- Carolina Constantin
- Monica Neagu
- Teodora Diana Supeanu
- Viorica Chiurciu
- Demetrios A. Spandidos
-
Affiliations: Immunology Laboratory, ‘Victor Babes’ National Institute of Pathology, 050096 Bucharest, Romania, Romvac Company S.A., 077190 Voluntari, Romania, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece - Published online on: April 30, 2020 https://doi.org/10.3892/etm.2020.8704
- Pages: 151-158
-
Copyright: © Constantin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Bryce J, Boschi-Pinto C, Shibuya K and Black RE: WHO Child Health Epidemiology Reference Group: WHO estimates of the causes of death in children. Lancet. 365:1147–1152. 2005.PubMed/NCBI View Article : Google Scholar | |
Qazi S, Aboubaker S, MacLean R, Fontaine O, Mantel C, Goodman T, Young M, Henderson P and Cherian T: Ending preventable child deaths from pneumonia and diarrhoea by 2025. Development of the integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea. Arch Dis Child. 100 (Suppl 1):S23–S28. 2015.PubMed/NCBI View Article : Google Scholar | |
Ujunwa F and Ezeonu C: Risk factors for acute respiratory tract infections in under-five children in enugu Southeast Nigeria. Ann Med Health Sci Res. 4:95–99. 2014.PubMed/NCBI View Article : Google Scholar | |
Munteanu AN, Surcel M, Constantin C and Neagu M: Syncytial virus respiratory infections in children - immunological aspects. Rev Biol Biomed Sci. 2:29–39. 2019. | |
Pasternak G, Lewandowicz-Uszyńska A and Pentoś K: Disorders of humoral immunity in children with IgG subclass deficiency and recurrent respiratory infections. Adv Exp Med Biol. 1108:99–106. 2018.PubMed/NCBI View Article : Google Scholar | |
Ivanova ON, Argunova EF, Alekseev SN, Ystugina TV, Varfolomeev AR, Troev IP, Kononova IV and Egorova VE: Adaptive mechanisms of the immune system in children in far north. Wiad Lek. 68:534–536. 2015.PubMed/NCBI | |
Liu Z, Qin Q, Wu C, Li H, Shou J, Yang Y, Gu M, Ma C, Lin W, Zou Y, et al: Downregulated NDR1 protein kinase inhibits innate immune response by initiating an miR146a-STAT1 feedback loop. Nat Commun. 9(2789)2018.PubMed/NCBI View Article : Google Scholar | |
Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, et al: Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee: Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc. 11:1640–1650. 2014.PubMed/NCBI View Article : Google Scholar | |
Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K and Marshall B: Pulmonary Clinical Practice Guidelines Committee: Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 187:680–689. 2013.PubMed/NCBI View Article : Google Scholar | |
Pasteur MC, Bilton D and Hill AT: British Thoracic Society Bronchiectasis non-CF Guideline Group: British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 65 (Suppl 1):i1–i58. 2010.PubMed/NCBI View Article : Google Scholar | |
McCaskill JL, Ressel S, Alber A, Redford J, Power UF, Schwarze J, Dutia BM and Buck AH: Broad-spectrum inhibition of respiratory virus infection by MicroRNA mimics targeting p38 MAPK signaling. Mol Ther Nucleic Acids. 7:256–266. 2017.PubMed/NCBI View Article : Google Scholar | |
Ge Y and Sun S: Estimation of coronavirus disease case-fatality risk in real time. Emerg Infect Dis: Apr 21, 2020 (Epub ahead of print). | |
Corti D, Passini N, Lanzavecchia A and Zambon M: Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome. J Infect Public Health. 9:231–235. 2016.PubMed/NCBI View Article : Google Scholar | |
Sparrow E, Friede M, Sheikh M and Torvaldsen S: Therapeutic antibodies for infectious diseases. Bull World Health Organ. 95:235–237. 2017.PubMed/NCBI View Article : Google Scholar | |
Graham BS and Ambrosino DM: History of passive antibody administration for prevention and treatment of infectious diseases. Curr Opin HIV AIDS. 10:129–134. 2015.PubMed/NCBI View Article : Google Scholar | |
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, et al: Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA: Mar 27, 2020 (Epub ahead of print). | |
Ancuceanu R and Neagu M: Immune based therapy for melanoma. Indian J Med Res. 143:135–144. 2016.PubMed/NCBI View Article : Google Scholar | |
Casadevall A, Dadachova E and Pirofski LA: Passive antibody therapy for infectious diseases. Nat Rev Microbiol. 2:695–703. 2004.PubMed/NCBI View Article : Google Scholar | |
Warr GW, Magor KE and Higgins DA: IgY: Clues to the origins of modern antibodies. Immunol Today. 16:392–398. 1995.PubMed/NCBI View Article : Google Scholar | |
Carlander D, Stålberg J and Larsson A: Chicken antibodies: A clinical chemistry perspective. Ups J Med Sci. 104:179–189. 1999.PubMed/NCBI View Article : Google Scholar | |
Thomsen K, Christophersen L, Bjarnsholt T, Jensen PO, Moser C and Høiby N: Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model. J Cyst Fibros. 15:171–178. 2016.PubMed/NCBI View Article : Google Scholar | |
Nguyen HH, Tumpey TM, Park HJ, Byun Y-H, Tran LD, Nguyen VD, Kilgore PE, Czerkinsky C, Katz JM, Seong BL, et al: Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS One. 5(e10152)2010.PubMed/NCBI View Article : Google Scholar | |
Rahman S, Van Nguyen S, Icatlo FC Jr, Umeda K and Kodama Y: Oral passive IgY-based immunotherapeutics: A novel solution for prevention and treatment of alimentary tract diseases. Hum Vaccin Immunother. 9:1039–1048. 2013.PubMed/NCBI View Article : Google Scholar | |
Vega CG, Bok M, Vlasova AN, Chattha KS, Fernández FM, Wigdorovitz A, Parreño VG, Saif LJ and Salmon H: IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model. PLoS One. 7(e42788)2012.PubMed/NCBI View Article : Google Scholar | |
Torché AM, Le Dimna M, Le Corre P, Mesplède A, Le Gal S, Cariolet R and Le Potier MF: Immune responses after local administration of IgY loaded-PLGA microspheres in gut-associated lymphoid tissue in pigs. Vet Immunol Immunopathol. 109:209–217. 2006.PubMed/NCBI View Article : Google Scholar | |
Akita E, Jang C, Kitts D and Nakai S: Evaluation of allergenicity of egg yolk immunoglobulin Y and other egg proteins by passive cutaneous anaphylaxis. Food Agric Immunol. 11:191–201. 1999. | |
Kovacs-Nolan J and Mine Y: Egg yolk antibodies for passive immunity. Annu Rev Food Sci Technol. 3:163–182. 2012.PubMed/NCBI View Article : Google Scholar | |
Xu Y, Li X, Jin L, Zhen Y, Lu Y, Li S, You J and Wang L: Application of chicken egg yolk immunoglobulins in the control of terrestrial and aquatic animal diseases: A review. Biotechnol Adv. 29:860–868. 2011.PubMed/NCBI View Article : Google Scholar | |
Zhang X, Calvert RA, Sutton BJ and Doré KA: IgY: A key isotype in antibody evolution. Biol Rev Camb Philos Soc. 92:2144–2156. 2017.PubMed/NCBI View Article : Google Scholar | |
Muller S, Schubert A, Zajac J, Dyck T and Oelkrug C: IgY antibodies in human nutrition for disease prevention. Nutr J. 14(109)2015.PubMed/NCBI View Article : Google Scholar | |
Gilgunn S, Millán Martín S, Wormald MR, Zapatero-Rodríguez J, Conroy PJ, O'Kennedy RJ, Rudd PM, Saldova R and Mondelli MU: Comprehensive N-Glycan profiling of avian immunoglobulin Y. PLoS One. 11(e0159859)2016.PubMed/NCBI View Article : Google Scholar | |
Liu L: Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins. J Pharm Sci. 104:1866–1884. 2015.PubMed/NCBI View Article : Google Scholar | |
Abbas AT, El-Kafrawy SA, Sohrab SS and Azhar EIA: IgY antibodies for the immunoprophylaxis and therapy of respiratory infections. Hum Vaccin Immunother. 15:264–275. 2019.PubMed/NCBI View Article : Google Scholar | |
Amro WA, Al-Qaisi W and Al-Razem F: Production and purification of IgY antibodies from chicken egg yolk. J Genet Eng Biotechnol. 16:99–103. 2018.PubMed/NCBI View Article : Google Scholar | |
Hoffman W, Lakkis FG and Chalasani G: B cells, antibodies, and more. Clin J Am Soc Nephrol. 11:137–154. 2016.PubMed/NCBI View Article : Google Scholar | |
Michael A, Meenatchisundaram S, Parameswari G, Subbraj T, Selvakumaran R and Ramalingam S: Chicken egg yolk antibodies (IgY) as an alternative to mammalian antibodies. Indian J Sci Technol. 3:468–474. 2010. | |
Esmailnejad A, Abdi-Hachesoo B, Hosseini Nasab E and Shakoori M: Production, purification, and evaluation of quail immunoglobulin Y against Salmonella typhimurium and Salmonella enteritidis. Mol Immunol. 107:79–83. 2019. | |
Ranjbar M, Behrouz B, Norouzi F and Mousavi Gargari SL: Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models. Mol Immunol. 116:98–105. 2019.PubMed/NCBI View Article : Google Scholar | |
Thomsen K, Christophersen L, Jensen PØ, Bjarnsholt T, Moser C and Høiby N: Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils. Hum Vaccin Immunother. 12:1690–1699. 2016.PubMed/NCBI View Article : Google Scholar | |
Thomsen K, Christophersen L, Bjarnsholt T, Jensen PØ, Moser C and Høiby N: Anti-Pseudomonas aeruginosa IgY antibodies induce specific bacterial aggregation and internalization in human polymorphonuclear neutrophils. Infect Immun. 83:2686–2693. 2015.PubMed/NCBI View Article : Google Scholar | |
Thirumalai D, Visaga Ambi S, Vieira-Pires RS, Xiaoying Z, Sekaran S and Krishnan U: Chicken egg yolk antibody (IgY) as diagnostics and therapeutics in parasitic infections - A review. Int J Biol Macromol. 136:755–763. 2019.PubMed/NCBI View Article : Google Scholar | |
Pereira EPV, van Tilburg MF, Florean EOPT and Guedes MIF: Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review. Int Immunopharmacol. 73:293–303. 2019.PubMed/NCBI View Article : Google Scholar | |
Dunkelberger JR and Song WC: Complement and its role in innate and adaptive immune responses. Cell Res. 20:34–50. 2010.PubMed/NCBI View Article : Google Scholar | |
Munhoz LS, Vargas GDÁ, Fischer G, Lima M, Esteves PA and Hübner SO: Avian IgY antibodies: Characteristics and applications in immunodiagnostic. Cienc Rural. 44:153–160. 2014. | |
Pauly D, Chacana PA, Calzado EG, Brembs B and Schade R: IgY technology: Extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation. J Vis Exp. 2011(3084)2011.PubMed/NCBI View Article : Google Scholar | |
Polanowski A, Zabłocka A, Sosnowska A, Janusz M and Trziszka T: Immunomodulatory activity accompanying chicken egg yolk immunoglobulin Y. Poult Sci. 91:3091–3096. 2012.PubMed/NCBI View Article : Google Scholar | |
Zhou X, Wang Y, Ahn DU and Cai Z: An easy and simple separation method for Fc and Fab fragments from chicken immunoglobulin Y (IgY). J Chromatogr B Analyt Technol Biomed Life Sci. 1141(122011)2020.PubMed/NCBI View Article : Google Scholar | |
da Silva MC, Schaefer R, Gava D, Souza CK, da Silva Vaz I Jr, Bastos AP and Venancio EJ: Production and application of anti-nucleoprotein IgY antibodies for influenza A virus detection in swine. J Immunol Methods. 461:100–105. 2018.PubMed/NCBI View Article : Google Scholar | |
Nagaraj S, Ramlal S, Kingston J and Batra HV: Development of IgY based sandwich ELISA for the detection of staphylococcal enterotoxin G (SEG), an egc toxin. Int J Food Microbiol. 237:136–141. 2016.PubMed/NCBI View Article : Google Scholar | |
Grzywa R, Łupicka-Słowik A, Walczak M, Idzi M, Bobrek K, Boivin S, Gaweł A, Stefaniak T, Oleksyszyn J and Sieńczyk M: Highly sensitive detection of cancer antigen 15-3 using novel avian IgY antibodies. ALTEX. 31:43–52. 2014.PubMed/NCBI View Article : Google Scholar | |
Ferreira A Jr, Santos JP, Bassi PB, Bittar JFF and Bittar ER: IgY-technology applied to studies of toxoplasma gondii infection. In: Toxoplasmosis. IntechOpen, 2017. https://www.intechopen.com/books/toxoplasmosis/igy-technology-applied-to-studies-of-toxoplasma-gondii-infection. Accessed June 14, 2017. | |
Bayat M, Khabiri A and Hemati B: Development of IgY-based sandwich ELISA as a robust tool for rapid detection and discrimination of toxigenic Vibrio cholerae. Can J Infect Dis Med Microbiol. 2018(e4032531)2018.PubMed/NCBI View Article : Google Scholar | |
Łupicka-Słowik A, Grzywa R, Leporowska E, Procyk D, Oleksyszyn J and Sieńczyk M: Development and evaluation of an immunoglobulin Y-based ELISA for measuring prostate specific antigen in human serum. Ann Lab Med. 39:373–380. 2019.PubMed/NCBI View Article : Google Scholar | |
Eisfeld AJ, Neumann G and Kawaoka Y: At the centre: Influenza A virus ribonucleoproteins. Nat Rev Microbiol. 13:28–41. 2015.PubMed/NCBI View Article : Google Scholar | |
Rajic A, Stehmann C, Autelitano DJ, Vrkic AK, Hosking CG, Rice GE and Ilag LL: Protein depletion using IgY from chickens immunised with human protein cocktails. Prep Biochem Biotechnol. 39:221–247. 2009.PubMed/NCBI View Article : Google Scholar | |
Elms P: Advantages of multidimensional (Multi-D) chromatography using the NGC™ chromatography system over traditional sequential chromatography. Bulletin 6694. Bio-Rad Laboratories, Inc., Hercules, CA, 2016. | |
Casadevall A and Scharff MD: Return to the past: The case for antibody-based therapies in infectious diseases. Clin Infect Dis. 21:150–161. 1995.PubMed/NCBI View Article : Google Scholar | |
Baxter D: Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond). 57:552–556. 2007.PubMed/NCBI View Article : Google Scholar | |
Patterson R, Youngner JS, Weigle WO and Dixon FJ: The metabolism of serum proteins in the hen and chick and secretion of serum proteins by the ovary of the hen. J Gen Physiol. 45:501–513. 1962.PubMed/NCBI View Article : Google Scholar | |
Rose ME, Orlans E and Buttress N: Immunoglobulin classes in the hen's egg: Their segregation in yolk and white. Eur J Immunol. 4:521–523. 1974.PubMed/NCBI View Article : Google Scholar | |
Hamal KR, Burgess SC, Pevzner IY and Erf GF: Maternal antibody transfer from dams to their egg yolks, egg whites, and chicks in meat lines of chickens. Poult Sci. 85:1364–1372. 2006.PubMed/NCBI View Article : Google Scholar | |
Helmenstine AM: An introduction to active immunity and passive immunity. ThoughtCo, 2019. https://www.thoughtco.com/active-immunity-and-passive-immunity-4134137. Accessed April 29, 2020. | |
Chalghoumi R, Marcq C, Théwis A, Portetelle D and Beckers Y: Effects of feed supplementation with specific hen egg yolk antibody (immunoglobin Y) on Salmonella species cecal colonization and growth performances of challenged broiler chickens. Poult Sci. 88:2081–2092. 2009.PubMed/NCBI View Article : Google Scholar | |
Gadde U, Rathinam T and Lillehoj HS: Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases - A review. Anim Health Res Rev. 16:163–176. 2015.PubMed/NCBI View Article : Google Scholar | |
Eibl MM: History of immunoglobulin replacement. Immunol Allergy Clin North Am. 28:737–764, viii. 2008.PubMed/NCBI View Article : Google Scholar | |
Hsu JL and Safdar N: Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases. Infect Dis Clin North Am. 25:773–788. 2011.PubMed/NCBI View Article : Google Scholar | |
Weltzin R and Monath TP: Intranasal antibody prophylaxis for protection against viral disease. Clin Microbiol Rev. 12:383–393. 1999.PubMed/NCBI | |
Rahman S, Higo-Moriguchi K, Htun KW, Taniguchi K, Icatlo FC Jr, Tsuji T, Kodama Y, Van Nguyen S, Umeda K, Oo HN, et al: Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Vaccine. 30:4661–4669. 2012.PubMed/NCBI View Article : Google Scholar | |
Li X, Wang L, Zhen Y, Li S and Xu Y: Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: A review. J Anim Sci Biotechnol. 6(40)2015.PubMed/NCBI View Article : Google Scholar | |
Thu HM, Myat TW, Win MM, Thant KZ, Rahman S, Umeda K, Nguyen SV, Icatlo FC Jr, Higo-Moriguchi K, Taniguchi K, et al: Chicken egg yolk antibodies (IgY) for prophylaxis and treatment of rotavirus diarrhea in human and animal neonates: A concise review. Han-gug Chugsan Sigpum Hag-hoeji. 37:1–9. 2017.PubMed/NCBI View Article : Google Scholar | |
Jensenius JC, Andersen I, Hau J, Crone M and Koch C: Eggs: Conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods. 46:63–68. 1981.PubMed/NCBI View Article : Google Scholar | |
Ikemori Y, Peralta RC, Kuroki M, Yokoyama H and Kodama Y: Research note: Avidity of chicken yolk antibodies to enterotoxigenic Escherichia coli fimbriae. Poult Sci. 72:2361–2365. 1993.PubMed/NCBI View Article : Google Scholar | |
Gassmann M, Thömmes P, Weiser T and Hübscher U: Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4:2528–2532. 1990.PubMed/NCBI View Article : Google Scholar | |
Sharma JM: Introduction to poultry vaccines and immunity. Adv Vet Med. 41:481–494. 1999.PubMed/NCBI View Article : Google Scholar | |
Perlman S and Netland J: Coronaviruses post-SARS: Update on replication and pathogenesis. Nat Rev Microbiol. 7:439–450. 2009.PubMed/NCBI View Article : Google Scholar | |
Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, et al: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:1394–1399. 2003.PubMed/NCBI View Article : Google Scholar | |
Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, et al: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 348:1967–1976. 2003.PubMed/NCBI View Article : Google Scholar | |
Fu CY, Huang H, Wang XM, Liu YG, Wang ZG, Cui SJ, Gao HL, Li Z, Li JP and Kong XG: Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens. J Virol Methods. 133:112–115. 2006.PubMed/NCBI View Article : Google Scholar | |
Cheng VC, Lau SK, Woo PC and Yuen KY: Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 20:660–694. 2007.PubMed/NCBI View Article : Google Scholar | |
Gavi, The Vaccine Alliance: The latest in the COVID-19 vaccine race. https://www.gavi.org/vaccineswork/covid-19-vaccine-race. Accessed March 24, 2020. | |
Mail Online: FDA approves first US coronavirus treatment: Doctors across the US can now treat the sickest Americans with plasma from recovered patients. https://www.dailymail.co.uk/health/article-8147631/Can-blood-coronavirus-survivors-treat-newly-ill.html. Accessed March 24, 2020. | |
Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, et al: Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1. Mol Med Rep. 4:209–214. 2011.PubMed/NCBI View Article : Google Scholar | |
Wen J, Zhao S, He D, Yang Y, Li Y and Zhu S: Preparation and characterization of egg yolk immunoglobulin Y specific to influenza B virus. Antiviral Res. 93:154–159. 2012.PubMed/NCBI View Article : Google Scholar | |
Yang YE, Wen J, Zhao S, Zhang K and Zhou Y: Prophylaxis and therapy of pandemic H1N1 virus infection using egg yolk antibody. J Virol Methods. 206:19–26. 2014.PubMed/NCBI View Article : Google Scholar | |
Wallach MG, Webby RJ, Islam F, Walkden-Brown S, Emmoth E, Feinstein R and Gronvik KO: Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice. Clin Vaccine Immunol. 18:1083–1090. 2011.PubMed/NCBI View Article : Google Scholar | |
Ferella A, Bellido D, Chacana P and Wigdorovitz A: DusSantos MJ and Mozgovoj MV: Chicken egg yolk antibodies against bovine respiratory syncytial virus neutralize the virus in vitro. Procedia Vaccinol. 6:33–38. 2012. | |
Tsitoura E, Bibaki E, Bolaki M, Vasarmidi E, Trachalaki A, Symvoulakis EK, Spandidos DA and Antoniou KM: [Comment] Treatment strategies to fight the new coronavirus SARS-CoV-2: A challenge for a Rubik's Cube solver. Exp Ther Med (In Press). | |
Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence of coronavirus (Review). Int J Mol Med. 45:1631–1643. 2020.PubMed/NCBI View Article : Google Scholar | |
Lee W, Syed Atif A, Tan SC and Leow CH: Insights into the chicken IgY with emphasis on the generation and applications of chicken recombinant monoclonal antibodies. J Immunol Methods. 447:71–85. 2017.PubMed/NCBI View Article : Google Scholar | |
Spillner E, Braren I, Greunke K, Seismann H, Blank S and du Plessis D: Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy. Biologicals. 40:313–322. 2012.PubMed/NCBI View Article : Google Scholar |